Title : Activity of deacetylase inhibitor panobinostat (LBH589) in cutaneous T-cell lymphoma models: Defining molecular mechanisms of resistance.

Pub. Date : 2010 Nov 1

PMID : 20127862






3 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Panobinostat (LBH589) is a highly potent deacetylase inhibitor that has demonstrated clinical efficacy in patients with advanced cutaneous T-cell lymphoma (CTCL). Panobinostat TSPY like 2 Homo sapiens
2 Panobinostat (LBH589) is a highly potent deacetylase inhibitor that has demonstrated clinical efficacy in patients with advanced cutaneous T-cell lymphoma (CTCL). Panobinostat TSPY like 2 Homo sapiens
3 Interestingly, panobinostat could induce cytotoxicity in vorinostat-resistant CTCL cells by downregulating phosphorylated STAT3 and STAT5 proteins. Panobinostat TSPY like 2 Homo sapiens